Publication | Closed Access

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: A proton magnetic resonance spectroscopy study

Schizophrenic PatientsPsychiatryPsychopharmacologySchizophreniaNeuropsychiatryNeurophysiological BiomarkersNeuroimagingNeuroscienceBiological PsychiatryNeurologyMedicineSocial SciencesVivo Metabolites